Portfolio company
CorFlow Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This medical device company develops a platform to diagnose and treat microvascular obstruction in heart attack patients for interventional cardiologists.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CorFlow Therapeutics AG
This company develops medical devices for diagnosing and treating microvascular obstruction in heart attack patients for use by interventional cardiologists in catheterisation laboratories.
Miracor Medical SA
This company develops a pressure-controlled intermittent coronary sinus occlusion system to treat patients with impaired cardiac function and heart attacks.
Robocath
This company develops robotic platforms for interventional cardiology to assist healthcare professionals in treating vascular diseases and performing coronary angioplasty.
Medyria AG
The company develops sensor-equipped microcatheters that measure blood flow velocity for interventional cardiologists to diagnose ischemic heart conditions.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
Echopoint Medical
The company develops a microcatheter system for cardiologists to diagnose coronary heart conditions and measure physiology within clinical settings.
SpectraWAVE
This company develops intravascular imaging systems and AI-enabled physiology tools for interventional cardiologists to treat and prevent coronary artery disease.
CorWave
This company develops implantable heart pumps with membrane technology to provide pulsatile blood flow for patients suffering from advanced heart failure.
